Anti-Stroke Biologics: From Recombinant Proteins to Stem Cells and Organoids

The authors introduce the current or promising recombinant proteins for thrombolysis therapy in ischemic stroke and highlight the promise and challenges of stem cells and cerebral organoids in stroke therapy.